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SUMMARY
Vestibular evoked myogenic potentials (VEMPs) are increasingly used for different pathologies with new clinical insights. Although the 
study of otolithic function selectively in both its saccular (cervical VEMPs) and utricular (ocular VEMPs) parts does not represent a recent 
achievement, the clinical utility of this tool is still emerging. The aim of the present report is to define advances in application of VEMPs 
in diagnosis and clinical study of vestibular neuritis, Ménière’s disease and benign paroxysmal positional vertigo. To perform a systematic 
review of the literature, three appropriate strings were run in PubMed to retrieve dedicated articles. A double cross-check was performed 
on citations and two independent investigators independently reviewed all full-text articles and performed a comprehensive quality assess-
ment. Of 140 articles identified, 26 articles were included, comprising a total of 1,181 patients affected by vestibular neuritis (296 subjects), 
Ménière’s disease (378 patients) and benign paroxysmal positional vertigo (507 patients). Overall, the use of both cVEMP and oVEMP 
appeared particularly useful in improving the topographic diagnosis of vestibular neuritis. Most (n = 8) of the studies dedicated to Ménière’s 
disease and benign paroxysmal positional vertigo (10 overall) also reported significantly abnormal VEMP values compared to healthy con-
trols. Although further reports will be necessary to better define normal threshold levels of VEMPs for each pathology, our review suggests 
that VEMPs may represent a useful aid in improving the diagnostic accuracy for these three common vestibular pathologies.
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RIASSUNTO 
Attualmente l’applicazione dei potenziali evocati vestibolari miogenici (VEMPs) sta crescendo in molte e differenti patologie. La possibilità di stu-
diare la funzione vestibolare in modo selettivo sia nel sacculo (VEMPs cervicali) sia nell’utricolo (VEMPs oculari) rappresenta una possibilità 
recentemente acquisita e l’utilità di tali indagini strumentali sta ancora emergendo e sempre meglio delineandosi. Lo scopo della nostra revisione è 
stato quello di definire per quanto possibile le novità nell’applicazione dei VEMPs per la diagnosi e l’approfondimento clinico di tre importanti entità 
patologiche: la neurite vestibolare, la malattia di Ménière e la vertigine posizionale benigna. Per realizzare questa revisione sistematica abbiamo 
quindi utilizzato tre differenti stringhe di parole chiave su PubMed ricercando in tal modo tutti gli articoli attinenti a queste tematiche. Una doppia 
verifica incrociata è stata eseguita da due degli autori prima su tutti i titoli scaturiti dalla ricerca e poi sugli specifici testi degli articoli selezionati 
al fine di poterne accertarne la qualità e la effettiva pertinenza. Su un totale di 140 articoli identificati, 26 studi sono stati inclusi nella revisione. 
Questi studi comprendevano 1.181 pazienti affetti rispettivamente da neurite vestibolare (296 soggetti), malattia di Ménière (378 soggetti) e vertigine 
parossistica benigna (507 soggetti). Per quanto concerne la neurite vestibolare complessivamente l’utilizzo dei cVEMPs e degli oVEMPs è apparso 
particolarmente utile nel migliorare l’accuratezza della diagnosi topografica della malattia. Sia per la malattia di Ménière che per la vertigine paros-
sistica posizionale benigna ben 8 studi su 10 che comprendevano anche un gruppo controllo di pazienti sani hanno mostrato come la registrazione dei 
VEMPs sia risultata significativamente anormale nei soggetti patologici rispetto a quelli sani. Sebbene ulteriori studi saranno certamente necessari 
per meglio definire le soglie di normalità nei valori dei VEMPs per ogni singola entità patologica qui analizzata, al momento possiamo concludere 
che la nostra revisione indica la reale utilità della registrazione dei VEMPs. Infatti se integrata alle altre opzioni strumentali disponibili essa sembra 
realmente poter garantire un ulteriore innalzamento nella qualità di inquadrare clinicamente queste tre patologie vertiginose.
PAROLE CHIAVE: VEMPs • Malattia di Ménière • Neurite vestibolare • BPPV • Vertigine periferica
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Introduction
Vestibular evoked myogenic potentials (VEMPs) are short 
latency electromyographic responses that can be recorded 
from various muscles during the contraction phase in re-
sponse to acoustic stimulus. VEMPs recorded from ipsi-
lateral sternocleidomastoid muscle known as “cervical 
VEMP” (cVEMP) are a clinical demonstration of the ves-
tibulo-collic reflex. cVEMP responses are characterised by 
biphasic waves with initial positivity (p13) followed by a 
negative wave (n23). The cVEMP pathway is believed to 
originate in the saccular macula and continues through the 
vestibular nerve and nucleus, vestibulospinal tracts, spinal 
motor nucleus and the sternocleidomastoid muscles 1.
Recently, a myogenic response recorded from contralater-
al extraocular muscles in response to acoustic stimuli has 
been reported to be a manifestation of crossed vestibulo-
ocular reflex and named ‘‘ocular VEMP’’ (oVEMP). The 
oVEMP pathway is thought to travel through the medial 
longitudinal fasciculus, oculomotor nuclei and nerves and 
extraocular muscles after the activation of the vestibular 
nerve and nucleus 2. oVEMP responses are characterised 
by biphasic waves with an initial negative peak (n1) fol-
lowed by a positive peak (p1) 1.
The study of otolithic function in both its saccular 
(cVEMPs) and utricular (oVEMPs) parts represents a 
milestone similar to that marked by the introduction of the 
caloric test, as the diagnosis and prognosis of numerous 
vestibular diseases can be influenced by such findings 3. 
Moreover, VEMP recording is a simple and rapid method 
that is well tolerated by subjects, and easily implementable 
in a laboratory equipped for recording evoked potentials. 
For these reasons, the VEMP recording test has become 
an important diagnostic tool, particularly in evaluation of 
peripheral vestibular disorders. 
At present, cVEMP responses have been shown to be par-
ticularly useful in assessment of patients with “superior 
semicircular canal dehiscence” presenting a lower-than-
normal threshold for elicitation of the cVEMP response 
in the affected ear  4. However, VEMPs are also thought 
to provide useful information about brainstem functions, 
as the neural pathway of both VEMPs pass through the 
brainstem, and several studies have described cVEMP 
and oVEMP abnormalities in brainstem lesions 5-7.
Undoubtedly, in recent years the popularity of this type of 
vestibular testing is on the increase, and different reports 
have been published about the utility of VEMPs in ves-
tibular and otologic pathologies.
The aim of this systematic review was to define the ad-
vances of the application of VEMPs to three frequent ves-
tibular pathologies, as outlined in the recent literature.
Materials and methods
In April 2017, a computerised MEDLINE search was per-
formed using the PubMed service of the U.S. National 
Library of Medicine; the following 3 search strings were 
run:
1. “Ménière Disease”[Mesh] OR  “Endolymphatic 
Hydrops”[Mesh] AND “Vestibular Evoked Myogenic 
Potentials”[Mesh];
2. “Vestibular Neuronitis”[Mesh] OR “Vestibular 
neuritis”[Mesh] AND “Vestibular Evoked Myogenic 
Potentials”[Mesh];
3. “Benign Paroxysmal Positional Vertigo”[Mesh] AND 
“Vestibular Evoked Myogenic Potentials”[Mesh].
Overall, the initial search returned a total of 140 results. 
Abstracts and titles obtained were screened independently 
by two of the authors (F.M.G. and M.R.), who subsequent-
ly met to discuss disagreements on citation inclusion. 
Inclusion criteria for citations were:
• articles reporting sufficient number of patients 
(> 10 subjects).
Exclusion criteria for citations were: 
• analysis including cohorts of patients affected by oth-
ers vestibular pathologies;
• articles concerning different instrumental methods than 
cVEMPs or oVEMPs.
Of the 140 articles, 36 met initial inclusion criteria ac-
cording to both authors (FMG and MR), and were thus 
obtained and reviewed in detail by the same two authors, 
who met and discussed disagreements on article inclusion. 
Inclusion criteria for full text articles identified were:
• sufficient and accurate description of VEMPs recording 
system;
• sufficient and accurate description of pathologies and 
clinical features.
Exclusion criteria were:
• lack of sufficient analysis and presentation of data;
• inclusion of patients with probable or not definite 
diagnosis.
A total of 12 studies were excluded because of insufficient 
data about recording VEMPs (n  =  4), lack of sufficient 
analysis of presented data (n = 6), or patient redundancy 
(n = 2). 
An additional manual check was performed on the refer-
ences included in the articles and two additional studies 
were identified and confirmed to meet the inclusion crite-
ria. The main information was extracted and analysed for 
all included studies.
Results
After an initial check, full-text retrieval and manual cross-
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checking of references included in the articles, a total of 
26 studies, including 1181 subjects, clearly met the inclu-
sion criteria and were chosen for analysis (Figure 1). The 
main characteristics of these selected studies are outlined 
in Tables I, II and III. 
Overall, the number of patients in each study included in 
this analysis varied from 12 to 134. There were 6 stud-
ies (including 296 patients) investigating VN, 10 studies 
(including 378 patients) dedicated to MD and 13 studies 
(including 507 patients) investigating BPPV. 
All VN dedicated studies performed cVEMPs, while 
oVEMPs responses were recorded in only 3 of the studies. 
Of the 10 MD studies, cVEMPs was performed in 7 and 
oVEMPs in 3 studies. Of the 13 articles analysing BPPV 
patients, 8 investigated cVEMPs while only 1  study re-
ported recording oVEMPs. 
Overall, abnormal VEMPs recording rates for VN ranged 
from 36.6% to 80% (Table  I). A significant correlation 
between the presence of VEMPs abnormalities and pa-
thology was reported in 5 of the MD studies; amplitude 
reduction was the most frequently observed alteration 
(Table  II). Furthermore, half of the BPPV articles (4/8) 
found a significant correlation between affected patients 
and VEMP abnormalities compared to control groups 
(Table III).
Vestibular neuritis 
The vestibular nerve is composed of the superior vestibu-
lar nerve (utricular nerve and superior and lateral ampullary 
nerves) and the inferior vestibular nerve (saccular nerve and 
posterior ampullary nerve) 8. Vestibular neuritis (VN) is a 
clinical entity defined by an episode of prolonged vertigo 
associated with unilateral peripheral vestibular hypofunc-
tion 9. It may affect either the entire vestibular nerve or each 
division of the vestibular nerve separately 10.
In patients who present selective involvement of the su-
perior vestibular nerve (superior VN), the function of the 
horizontal and anterior canals is impaired, as shown by 
abnormal calorics and deficient head-impulse tests in the 
plane of the involved horizontal and anterior canals 11. 
In such patients, the utricular afferents that traverse the 
superior vestibular nerve are likely to have absent or re-
duced function. However, the function of the inferior divi-
sion of the vestibular nerve is spared, as shown by normal 
head-impulse tests during stimulation of the posterior ca-
nal and normal cVEMP 12 13.
By contrast, VN selectively affecting the inferior division 
may show reduced or absent ipsilesional cVEMP in the 
presence of functioning horizontal and anterior semicir-
cular canals and utricle, as determined by normal calorics 
and horizontal head-impulse tests 14.
Fig. 1. Flowchart showing studies’ selection.
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Functional impairment of the entire vestibular nerve (su-
perior and inferior division) and a single superior division 
involvement in VN are the most common conditions  15, 
and selective inferior vestibular nerve damage has recent-
ly been described 16.
Some authors have investigated the role of VEMPs re-
cording in improving the diagnostic accuracy for patients 
affected by VN. Hong et al. 17 studied 134 patients with 
VN. Overall 49 (36.6%) showed an abnormal cVEMP re-
sponse. In particular, a prolonged p13 latency was noted 
in 29  patients, while 25  patients presented a n23 pro-
longed latency. Increased cVEMP asymmetry was found 
in 27 patients. The authors speculated that 36.6% of all 
subjects in their study had lesions in the labyrinth or infe-
rior vestibular nerve. 
Vinciana et al. 18 analysed 41 patients diagnosed with VN. 
cVEMPs were performed and resulted abnormal in 21 
(51%) of 41 cases, the most common finding was an in-
crease in ipsilateral latencies for p1 and n1 peaks. 
Further, Nola et al.  19 performed cVEMP recording in a 
cohort of 20 patients affected by VN. Nine patients, pre-
senting a torsional nystagmus and bilateral normoreflexia 
after caloric labyrinth stimulation, had no cVEMP re-
sponse on the affected side (while the response was pre-
sent on the contralateral side). The authors concluded that 
these nine patients were affected by inferior VN.
The cVEMP examinations were then repeated after 8 days, 
1 month and 3 months. After 8 days, seven of the patients 
diagnosed with inferior branch VN showed an improve-
ment of cVEMP values while a complete reappearance of 
cVEMP after 1 month was noted in all nine patients. 
The findings of Shin et al. 14 strongly support the hypoth-
esis that oVEMPs response is mediated by the superior 
vestibular nerve. The authors examined 41 patients with 
acute VN, and on the basis of clinical findings (appear-
ance of mixed horizontal and torsional nystagmus; im-
paired horizontal SCC function on head-impulse test and 
caloric paresis > 25%; normal cVEMP and normal head-
impulse test for posterior SCC) 30  subjects affected by 
neuritis of the superior vestibular nerve were identified. 
Interestingly, all these patients presented normal cVEMP 
responses in the affected ear, indicating that the saccu-
lar otolithic receptors and their afferents, in the inferior 
vestibular nerve, were completely functional. In contrast, 
all 30 patients had an asymmetric oVEMP response with 
the p10 component either absent, markedly reduced or de-
layed, beneath the eye opposite to the affected ear. 
In a recent study, Magliulo et al.  3 prospectively evalu-
ated 40 patients affected by VN employing both cVEMPs 
and oVEMPs. Thirty-two of the 40 patients showed ab-
sent or abnormal oVEMPs at the first control, while only 
19 of the 40 patients showed absent or abnormal values 
of cVEMPs. With the aid of the video head impulse test 
(vHIT) the authors were able to classify the various patho-
logical findings with regards to the location of vestibular 
damage and number of vestibular organs involved. The 
superior vestibular nerve VN (30%), followed by the total 
VN (25%), were the most frequently involved entities.
Table I. Main characteristics of the studies analysed with correlations between vestibular neuritis (VN) and VEMPs responses. 
Authors Year No. of patients 
with definite 
VN
No. of healthy 
subjects in 
control group
Type 
of VEMPs 
Sound 
conduction
Stimuli Stimulation 
intensity
Stimulation 
frequencies
Significant 
findings in VEMPs 
responses
Hong et al. 17 2008 134 None cVEMP ACS Clicks 95 dB 2,000 Hz Abnormal values in 
49 (36.6%) patients
Vinciana and 
Lopez-Escamez 18
2010 41 None cVEMP ACS Tone bursts 129 dB 500 Hz Abnormal values in 
21 (51%) patients
Nola et al. 19 2011 20 None cVEMP ACS n.a. 130 dB 500 Hz Abnormal values in 
9 (45%) patients
Shin et al. 14 2012 41 60 cVEMP ACS Tone bursts 100 dB 1,000 Hz n.a.
oVEMP ACS Tone bursts 100 dB 1,000 Hz Abnormal values in 
30 (73.1%) patients
Walther and 
Blodow 20
2013 20 None cVEMP ACS Tone bursts 100 dB 500 Hz Abnormal values in 
9 (45%) patients
oVEMP ACS Tone bursts 100 dB 500 Hz Abnormal values in 
12 (60%) patients
Magliulo et al. 3 2014 40 None cVEMP ACS Logon 130 dB 500 Hz Abnormal values in 
19 (47.5%) patients
oVEMP BCS n.a. n.a. n.a. Abnormal values in 
32 (80%) patients
ACS: Air-Conducted Sound; BCS: Bone-Conducted Sound; n.a.: not available.
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Similary, Walther and Blodow 20 analysed 20 patients af-
fected by VN using both oVEMPs and cVEMPs in com-
bination with vHIT. The authors were able to differentiate 
4 types of VN (entire VN; superior VN; inferior VN; am-
pullary VN); entire VN and superior VN were the entities 
most frequently observed.
Ménière’s disease (MD)
Ménière’s disease (MD) is characterised by fluctuating hear-
ing loss, tinnitus, aural fullness and episodic vertigo  21  22. 
The histopathological correlate, endolymphatic hydrops, is 
observed most frequently in the cochlea and the saccule, fol-
lowed by the utricle and the semi-circular canals 23-25. 
Table II. Main characteristics of the studies analysed with correlations between Ménière’s disease (MD) and VEMPs responses. 
Authors Year No. of patients 
with definite 
MD
No. of healthy 
subjects in the 
control group
Type 
of VEMPs 
Sound 
conduction
Stimuli Stimulation 
intensity
Stimulation 
frequencies
Significant 
findings in VEMPs 
responses
Akkuzu et al. 34 2006 20 17 cVEMP ACS Tone bursts 100 dB 500 Hz Abnormal values 
(p < 0.001)
Hong et al. 17 2008 29 None cVEMP ACS Clicks 95 dB 2,000 Hz Abnormal values in 
20 (69%) patients
Kim-Lee et al. 42 2009 24 20 cVEMP ACS Tone bursts 90 dB 500-1,000 Hz Elevated frequency 
peak amplitude 
(p < 0.001) 
Winters et al. 37 2011 37 55 oVEMP ACS Tone bursts 120 dB 500-4,900 Hz Lower response 
rate (p < 0.05)
Higher asymmetry 
ratio (p < 0.05)
Lower amplitude 
(p < 0.05)
Kingma and 
Wit 36
2011 22 None cVEMP ACS Tone bursts 100 dB 250-500 Hz Lower amplitude in 
the affected ears 
(p < 0.05)
Taylor et al. 38 2011 60 35 cVEMP ACS Clicks 140 dB 500 Hz Abnormal values in 
24 (40%) patients
BCS Vibration 
pulses
n.a. n.a. Abnormal values 
in 13 
(22.8%) patients
oVEMP ACS Clicks 140 dB 500 Hz Abnormal values in 
30 (50%) patients
BCS Vibration 
pulses
n.a. n.a. Abnormal values in 
6 (10.2%) patients
Sandhu et al. 41 2012 12 8 cVEMP ACS Tone bursts 120 dB 250-500-750-
1,000-1,500-
2,000-3,000-
4,000 Hz
Lower amplitude 
(p < 0.05)
oVEMP ACS Tone bursts 120 dB 250-4,000 Hz Lower amplitude
(p < 0.05)
Egami et al. 35 2013 114 None cVEMP ACS Clicks/ 
Tone bursts 
95 dB 500 Hz Abnormal values in 
57 (50%) patients 
Silva et al. 61 2016 30 30 Combined 
cVEMP-
oVEMP
ACS Tone bursts 120 dB 500 Hz Mean latency 
values of n10 - 
p15 waves were 
higher than 
control group
Chen et al. 62 2016 30 30 cVEMP ACS Tone bursts 90 dB 500 Hz Abnormal 
responses in 12 
(40%) patients
oVEMP ACS Tone bursts 95 dB 500 Hz Abnormal 
responses in 5 
(16.7%) patients
ACS: Air-Conducted Sound; BCS: Bone-Conducted Sound; n.a.: not available.
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Table III. Main characteristics of the studies analysed with correlations between benign paroxysmal positional vertigo (BPPV) and VEMPs responses. 
Authors Year No. of patients 
with definite 
BPPV
No. of healthy 
subjects in 
control group
Type 
of VEMPs 
Sound 
conduction
Stimuli Stimulation 
intensity
Stimulation 
frequencies
Significant findings 
and correlations in 
VEMPs responses
Akkuzu et al. 34 2006 25 17 cVEMP ACS Tone bursts 500 dB 500 Hz Abnormal values 
(p=0.012)
Boleas-Aguirre 
et al. 50
2007 19 None cVEMP ACS Clicks 70-100 dB n.a. Absent responses in 
10 (52.4%) affected 
ears vs 5 (26.3%) 
healthy ears
Hong et al. 17 2008 62 None cVEMP ACS Clicks 95 dB 500 Hz Abnormal values in 
24 (40%) patients
Yang et al. 51 2008 41 92 cVEMP ACS Clicks 95 dB n.a. No response in 11 
(27%) patients; 
Prolonged latencies 
(p<0.001)
Korres et al. 52 2011 27 30 cVEMP ACS Tone bursts 95 dB 500 Hz Abnormal values 
(p<0.005)
Longo et al. 55 2011 23 24 cVEMP ACS Logon 127 dB 500 Hz Abnormal values 
(p<0.001)
Lee et al. 53 2013 16 None cVEMP ACS Tone bursts 90 dB 500 Hz Abnormal values in 
5 (31.3%) patients 
oVEMP ACS Tone bursts 95 dB 500 Hz Abnormal values in 
4 (25%) patients 
Yetiser et al. 54 2014 102 15 cVEMP ACS Tone bursts 95 dB 500 Hz Abnormal values in 
24 (23.5%) patients
Xu et al. 56 2016 30 30 cVEMP ACS Tone bursts 90 dB 500 Hz Abnormal values 
in 9 (30%) BPPV 
patients vs 2 (6.6%) 
healthy patients
oVEMP ACS Tone bursts 95 dB 500 Hz Abnormal values in 
17 (56.7%) BPPV 
patients vs 1 (3.3%) 
healthy patient
Singh et al. 57 2015 31 31 cVEMP ACS Tone bursts 125 dB 500 Hz No significant group 
difference on any 
cVEMP parameters
oVEMP ACS Tone bursts 125 dB 500 Hz Peak-to-peak 
amplitude 
significantly smaller 
in the affected ears
Chang et al. 58 2017 65 None cVEMP ACS Tone bursts 95 dB 500 Hz Decreased interaural 
amplitude difference 
ratio at the affect 
side associated with 
persisting BPPV 
after manoeuver
Hoseinabadi 
et al. 59
2015 30 None cVEMP 
oVEMP
ACS Tone bursts 95 dB 500 Hz QoL is more 
compromised 
in patients with 
cVEMP and oVEMP 
abnormalities
Karatas et al. 60 2016 36 20 cVEMP ACS Tone bursts 100 dB 500 Hz Normalised 
amplitudes of BPPV 
patients significantly 
lower than those in 
the control group
QoL: Quality of Life; ACS: Air-Conducted Sound; n.a.: not available.
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The diagnosis of MD relies upon clinical presentation 
and pure tone audiometry, which in the early stages of 
the disease shows low frequency hearing loss in a “rising 
configuration” that later progresses to a flat hearing loss 
of moderate severity 26-29. 
Current standard vestibular testing consists of caloric 
stimulation of both ears using nystagmography to evalu-
ate the ear’s functionality. However, this test highlights 
disturbances in only 1 (the horizontal canal) of the 3 semi-
circular canals. Moreover, in patients with MD, the calori-
gram can show variable responses, and in many cases, test 
results are normal 30.
Initial reports using a standard fixed acoustic stimulus 
showed that a significant number (35%-54%) of patients 
with MD did not have cVEMPs present 31-33, so that au-
thors began to compare VEMPs values in patients affected 
by MD with those recorded in normal ears. 
Akkuzu et al.  34 found 10 (50%) abnormal cVEMP re-
sponses in 20 patients with MD. In particular, there were 
4 ears with no response while six ears presented a pro-
longed latency at p13. Among 29 subjects diagnosed with 
MD, Hong et al. 15 observed an abnormality of cVEMP in 
20 (69%) of them. In particular, increased cVEMP asym-
metry was noted in 14 (70%) patients followed by a pro-
longed p13 latency (9 patients, 45%).
Egami et al. 35 measuring cVEMP in 144 patients affected 
by MD and found abnormal values in 57 (50%) of them. 
It must be noted that among the same patients only 43 
(37.7%) showed no or decreased caloric responses on the 
affected side.
Kingma et al. 36 measured cVEMP in 22 patients affected 
by MD. On average, significantly lower VEMP ampli-
tudes were measured at the side of the affected ear for 
both stimulus frequencies (250 and 500 Hz).
Winters et al. 37 evaluated the changes of the oVEMP in a 
group of 37 patients with MD. The data showed that the 
oVEMP response rates in ears of patients with MD were 
dramatically lower (54% at 120 dB SPL; 29% at 115 dB 
SPL) than in normal subjects (98.2% at 120 dB SPL). 
Taylor et al. 38 investigated the prevalence of cVEMP and 
oVEMP on 60 patients with MD reporting 50% of abnor-
mality for oVEMP and 40% of abnormality for cVEMP 
responses. 
Some authors 39 40 reported a shift in dominant frequency 
away from the typical 500 to 1000 Hz for VEMPs record-
ed in patients with MD. On the basis of these observa-
tions, Sandhu et al. 41 confirmed the presence of this shift 
in dominant frequency for both cVEMP and oVEMP in 
patients with MD. Interestingly, the authors were able to 
evoke myogenic potentials in all ears tested: in healthy 
volunteers, the acoustic stimulus frequency at which the 
response amplitudes were largest was 500  Hz, while in 
subjects affected by MD this value shifted to higher fre-
quencies. 
Similar results were observed by Kim-Lee et al.  42 who 
analysed the cVEMP responses in a group of 24  sub-
jects with MD. Overall, cVEMP were present in 83% 
of affected ears, but were most reliably elicited at a tone 
burst stimulation frequency of 1,000  Hz. Moreover, the 
frequency peak amplitude ratios (FPA) in the MD group 
were significantly elevated compared with those of the 
control group. The authors concluded that FPA is elevated 
in MD and thus may represent a useful diagnostic crite-
rion in the diagnosis of this pathology. 
Another interesting study was published by Katayama et 
al. 43 who investigated the relationship between the pres-
ence of endolymphatic hydrops and cVEMP in patients 
with MD. Intratympanic injection with gadolinium dilut-
ed with saline was performed in 49 affected ears and after 
one day, 3 Tesla MRI and cVEMP were performed. Over-
all, cVEMP was present in 21 ears and absent in 28 ears. 
Endolymphatic hydrops was significantly associated with 
the absence of cVEMP. 
Benign paroxysmal positional vertigo (BPPV) 
Benign paroxysmal positional vertigo (BPPV) is the most 
common disorder of the peripheral vestibular system and 
characterised by episodes of vertigo associated with head 
movements 44 45. Although BPPV generally responds well 
to treatment, there is a significant rate of recurrence af-
ter the initial resolution 46. The recurrence rates during a 
1-year follow-up period have been reported to range from 
10% to 18% 47 48.
In explaining the pathophysiology of BPPV, the concept 
of a degenerative process that affects the macula of the 
utricle causing detachment of otoliths has gained popular 
support 49. However, in 30 affected ears with BPPV Akku-
zu et al. 34 found 9 (30%) ears showing abnormal cVEMP 
values. This finding suggested that the degenerative pro-
cess involved in BPPV might also affect the macula of the 
saccule. 
Similarly, Boleas-Aguirre et al.  50 analysed 19 patients 
diagnosed with BPPV of the posterior semi-circular ca-
nal. The authors found a lack of cVEMP response in 52% 
of the affected ears. When adjusted for bilateral absence, 
cVEMP response was absent in 20.3% of ears. The au-
thors concluded that some patients with BPPV show a 
certain degree of saccular dysfunction. 
Among 62 subjects diagnosed with BPPV, Hong et al. 15 
reported an abnormality of cVEMP in 16 (25.8%) of 
them. Yang et al.  51 investigated the clinical significance 
of cVEMP in a group of 41 patients affected by BPPV 
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in comparison to 92 healthy volunteers. Overall, 11 
(27%) patients in the BPPV group showed no response 
in VEMPs in the affected ear. Moreover, VEMPs showed 
prolonged p13 and n23 latencies in BPPV subjects com-
pared with those of the control group. 
Korres et al. 52 analysed 27 BPPV patients and noted that the 
percentage of abnormal cVEMP in the BPPV population 
was significantly higher than in the ears of control group. 
Lee et al.  53 investigated the usefulness of VEMP in pa-
tients presenting recurrent BPPV and reported interesting 
results. The authors analysed 16 subjects presenting recur-
rent BPPV and 20 patients with non-recurrent BPPV by 
cVEMP and oVEMP. Among the group of patients with 
recurrent BPPV, abnormal cVEMP responses were de-
tected in 5 (31.3%) subjects, while abnormal oVEMP re-
sponses resulted in 4 (25%) subjects. Between the 20 pa-
tients with non-recurrent BPPV, only 3 (15%) subjects 
overall showed abnormal cVEMP or abnormal oVEMP. 
Yetiser et al. 54 recently analysed a cohort of 102 patients 
affected by BPPV and reported similar findings. In total, 
24 (23.5%) patients presented a gross cVEMP abnormal-
ity (absence of VEMP in 6 and greater than 25% depres-
sion of the amplitude in 18). Abnormality of VEMPs was 
not correlated with age, severity of nystagmus or the site 
of canal involvement, but was significantly correlated 
with persistence or recurrence of symptoms.
Finally, Longo et al. 55, in their prospective study of 23 pa-
tients affected by BPPV and 24 healthy volunteers, found 
that the cVEMP among BPPV patients were altered in 14 
ears (30.4%) and absent in 5 (10.9%) affected ears and in 
2 (4.3%) non-affected ears. This value was significantly 
higher than the comparative control groups. 
Conclusions
Although official standard measurement parameters of 
normality must still be defined for VEMPs, it seems clear 
that this instrument will represent a novel and important 
vestibular examination for VP, MD and BPPV. In VN, 
VEMPs (cVEMP together with oVEMP) may represent 
a useful tool in improving topographic diagnosis, offer-
ing key information about prognosis and therapy. In MD, 
both cVEMP and oVEMP showed better sensitivity and 
specificity compared with the caloric test, but a wide vari-
ety of described alterations in VEMPs recordings among 
the studies analysed were noted, with amplitude reduction 
representing the most frequent finding. For this reason, 
additional studies are needed to accurately identify spe-
cific anomalies in VEMPs recording associated with MD. 
In VPPB, VEMPs may also be important in predicting 
pathological recurrences. 
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